The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of SEBI's Takeover Regulations from Arjan Lalchandani, who is associated with Dr Lalchandani Labs Ltd. This regulation requires promoters and members of the promoter group to report any acquisition or disposal of shares in the company. The specific details of whether the transaction was a buy or a sell, the number of shares involved, and the resulting change in shareholding are not provided in the headline. Arjan Lalchandani is part of the promoter group of the company. Shareholders will need to check the full disclosure on the BSE portal to understand the exact nature of the transaction and its impact on promoter holding.
This is a routine regulatory disclosure by a promoter-group member. Depending on whether it is an acquisition or disposal, it could signal continued promoter confidence or a trimming of holdings. Investors should review the detailed disclosure to assess any change in promoter shareholding pattern.